Published in J Periodontol on May 07, 2013
Enamelin is critical for ameloblast integrity and enamel ultrastructure formation. PLoS One (2014) 0.94
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58
Mutation of the gene encoding the enamel-specific protein, enamelin, causes autosomal-dominant amelogenesis imperfecta. Hum Mol Genet (2001) 2.18
Enamel defects and ameloblast-specific expression in Enam knock-out/lacz knock-in mice. J Biol Chem (2008) 2.05
Target gene analyses of 39 amelogenesis imperfecta kindreds. Eur J Oral Sci (2011) 1.97
ENAM mutations in autosomal-dominant amelogenesis imperfecta. J Dent Res (2005) 1.83
Mutational analysis of candidate genes in 24 amelogenesis imperfecta families. Eur J Oral Sci (2006) 1.77
Enamelin and autosomal-dominant amelogenesis imperfecta. Crit Rev Oral Biol Med (2003) 1.55
Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair. J Periodontol (2007) 1.50
A mouse model expressing a truncated form of ameloblastin exhibits dental and junctional epithelium defects. Matrix Biol (2009) 1.50
Amelogenesis imperfecta: genotype-phenotype studies in 71 families. Cells Tissues Organs (2011) 1.45
Phenotype of ENAM mutations is dosage-dependent. J Dent Res (2005) 1.42
Novel ENAM mutation responsible for autosomal recessive amelogenesis imperfecta and localised enamel defects. J Med Genet (2003) 1.40
A nonsense mutation in the enamelin gene causes local hypoplastic autosomal dominant amelogenesis imperfecta (AIH2). Hum Mol Genet (2002) 1.39
Identification of the enamelin (g.8344delG) mutation in a new kindred and presentation of a standardized ENAM nomenclature. Arch Oral Biol (2003) 1.39
Autosomal-dominant hypoplastic form of amelogenesis imperfecta caused by an enamelin gene mutation at the exon-intron boundary. J Dent Res (2002) 1.38
Enamelin (Enam) is essential for amelogenesis: ENU-induced mouse mutants as models for different clinical subtypes of human amelogenesis imperfecta (AI). Hum Mol Genet (2005) 1.30
A mutation in the enamelin gene in a mouse model. J Dent Res (2007) 1.10
Altered enamelin phosphorylation site causes amelogenesis imperfecta. J Dent Res (2010) 1.08
Identification of a novel mutation in the enamalin gene in a family with autosomal-dominant amelogenesis imperfecta. Arch Oral Biol (2007) 1.01
Candidate gene strategy reveals ENAM mutations. J Dent Res (2009) 0.97
The receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenic pathway is elevated in amelogenin-null mice. J Biol Chem (2003) 0.95
Autosomal dominant amelogenesis imperfecta associated with ENAM frameshift mutation p.Asn36Ilefs56. Clin Genet (2012) 0.93
Orthodontic treatment and periodontal status. J Periodontol (1979) 0.87
Distal cis-regulatory elements are required for tissue-specific expression of enamelin (Enam). Eur J Oral Sci (2008) 0.85
Root proximity as a risk factor for progression of alveolar bone loss: the Veterans Affairs Dental Longitudinal Study. J Periodontol (2008) 0.82
A histologic study of the width and nature of inter-radicular spaces in human adult pre-molars and molars. J Dent Res (1986) 0.81
[Genetic, clinical and molecular analysis of a family affected by amelogenesis imperfecta]. Rev Med Chil (2005) 0.80
Dental root resorption and repair: histology and histometry during physiological drift of rat molars. J Periodontal Res (2003) 0.78
Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol (2005) 3.24
Teriparatide and osseous regeneration in the oral cavity. N Engl J Med (2010) 3.08
Swallowed and aspirated dental prostheses and instruments in clinical dental practice: a report of five cases and a proposed management algorithm. J Am Dent Assoc (2014) 2.77
Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype. J Biol Chem (2002) 2.59
The effect of recombinant mouse amelogenins on the formation and organization of hydroxyapatite crystals in vitro. J Struct Biol (2005) 2.43
Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci U S A (2007) 2.39
FAM83H mutations in families with autosomal-dominant hypocalcified amelogenesis imperfecta. Am J Hum Genet (2008) 2.38
Enamel formation and amelogenesis imperfecta. Cells Tissues Organs (2007) 2.32
The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials (2007) 2.14
Enamel defects and ameloblast-specific expression in Enam knock-out/lacz knock-in mice. J Biol Chem (2008) 2.05
Target gene analyses of 39 amelogenesis imperfecta kindreds. Eur J Oral Sci (2011) 1.97
Functions of KLK4 and MMP-20 in dental enamel formation. Biol Chem (2008) 1.93
Induction of bone loss by pathobiont-mediated Nod1 signaling in the oral cavity. Cell Host Microbe (2013) 1.89
pH triggered self-assembly of native and recombinant amelogenins under physiological pH and temperature in vitro. J Struct Biol (2007) 1.79
Mutational analysis of candidate genes in 24 amelogenesis imperfecta families. Eur J Oral Sci (2006) 1.77
Dentin sialophosphoprotein is processed by MMP-2 and MMP-20 in vitro and in vivo. J Biol Chem (2006) 1.72
Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol (2009) 1.72
Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontol 2000 (2009) 1.66
Role of 20-kDa amelogenin (P148) phosphorylation in calcium phosphate formation in vitro. J Biol Chem (2009) 1.59
Enamelysin and kallikrein-4 mRNA expression in developing mouse molars. Eur J Oral Sci (2002) 1.59
Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am (2005) 1.56
Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair. J Periodontol (2007) 1.50
Porcine kallikrein-4 activation, glycosylation, activity, and expression in prokaryotic and eukaryotic hosts. Eur J Oral Sci (2002) 1.49
Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 (2007) 1.44
Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J Control Release (2006) 1.40
Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci (2007) 1.39
A nonsense mutation in the enamelin gene causes local hypoplastic autosomal dominant amelogenesis imperfecta (AIH2). Hum Mol Genet (2002) 1.39
Dentin glycoprotein: the protein in the middle of the dentin sialophosphoprotein chimera. J Biol Chem (2005) 1.38
Hierarchical self-assembly of amelogenin and the regulation of biomineralization at the nanoscale. Proc Natl Acad Sci U S A (2011) 1.38
Porcine dentin sialoprotein is a proteoglycan with glycosaminoglycan chains containing chondroitin 6-sulfate. J Biol Chem (2004) 1.33
Mutational spectrum of FAM83H: the C-terminal portion is required for tooth enamel calcification. Hum Mutat (2008) 1.28
Effects of phosphorylation on the self-assembly of native full-length porcine amelogenin and its regulation of calcium phosphate formation in vitro. J Struct Biol (2010) 1.28
Mutational hot spot in the DSPP gene causing dentinogenesis imperfecta type II. Hum Genet (2004) 1.26
Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther (2004) 1.26
Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis. J Periodontol (2007) 1.25
The nucleation and growth of calcium phosphate by amelogenin. J Cryst Growth (2007) 1.25
Consequences for enamel development and mineralization resulting from loss of function of ameloblastin or enamelin. Eur J Oral Sci (2009) 1.25
Growth factor delivery for oral and periodontal tissue engineering. Expert Opin Drug Deliv (2006) 1.24
Effect of kallikrein 4 loss on enamel mineralization: comparison with mice lacking matrix metalloproteinase 20. J Biol Chem (2011) 1.21
Platelet-derived growth factor applications in periodontal and peri-implant bone regeneration. Expert Opin Biol Ther (2011) 1.17
Platelet-derived growth factor gene delivery stimulates ex vivo gingival repair. Tissue Eng (2003) 1.16
Amelogenin-collagen interactions regulate calcium phosphate mineralization in vitro. J Biol Chem (2010) 1.14
FAM20A mutations can cause enamel-renal syndrome (ERS). PLoS Genet (2013) 1.14
Developmental biology and genetics of dental malformations. Orthod Craniofac Res (2007) 1.14
Clinical response of azithromycin as an adjunct to non-surgical periodontal therapy in smokers. J Periodontol (2005) 1.12
How do enamelysin and kallikrein 4 process the 32-kDa enamelin? Eur J Oral Sci (2006) 1.12
Tissue engineering bone-ligament complexes using fiber-guiding scaffolds. Biomaterials (2011) 1.12
Secreted protein kinases? Trends Biochem Sci (2013) 1.10
Porcine dentin sialophosphoprotein: length polymorphisms, glycosylation, phosphorylation, and stability. J Biol Chem (2008) 1.10
BMP gene delivery for alveolar bone engineering at dental implant defects. Mol Ther (2005) 1.09
Effect of rhPDGF-BB delivery on mediators of periodontal wound repair. Tissue Eng (2006) 1.09
Gene therapeutics for periodontal regenerative medicine. Dent Clin North Am (2006) 1.09
Astacin proteases cleave dentin sialophosphoprotein (Dspp) to generate dentin phosphoprotein (Dpp). J Bone Miner Res (2011) 1.08
RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol (2007) 1.08
Amelogenin nanoparticles in suspension: deviations from spherical shape and pH-dependent aggregation. Biomacromolecules (2010) 1.08
Proteomics and genetics of dental enamel. Cells Tissues Organs (2005) 1.07
Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial. Cell Transplant (2013) 1.07
Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Res Ther (2013) 1.05
Cell- and gene-based therapeutic strategies for periodontal regenerative medicine. J Periodontol (2011) 1.04
Biomimetic hybrid scaffolds for engineering human tooth-ligament interfaces. Biomaterials (2010) 1.03
A dentin sialophosphoprotein mutation that partially disrupts a splice acceptor site causes type II dentin dysplasia. J Endod (2008) 1.03
Growth factor delivery to re-engineer periodontal tissues. Curr Pharm Biotechnol (2002) 1.03
MMP-20 is predominately a tooth-specific enzyme with a deep catalytic pocket that hydrolyzes type V collagen. Biochemistry (2006) 1.02
Regulation of calcium phosphate formation by amelogenins under physiological conditions. Eur J Oral Sci (2011) 1.02
Enamel proteins and proteases in Mmp20 and Klk4 null and double-null mice. Eur J Oral Sci (2011) 1.02
Effect of rhPDGF-BB on bone turnover during periodontal repair. J Clin Periodontol (2006) 1.02
Comparative analysis of collagen membranes for the treatment of implant dehiscence defects. Clin Oral Implants Res (2003) 1.02
Image-based, fiber guiding scaffolds: a platform for regenerating tissue interfaces. Tissue Eng Part C Methods (2013) 1.02
The impact of primary hyperparathyroidism on the oral cavity. J Clin Endocrinol Metab (2006) 1.01
ITGB6 loss-of-function mutations cause autosomal recessive amelogenesis imperfecta. Hum Mol Genet (2013) 1.01
Characterization of porcine dentin sialoprotein (DSP) and dentin sialophosphoprotein (DSPP) cDNA clones. Eur J Oral Sci (2003) 1.01
Treatment of gingival recession using a collagen membrane with or without the use of demineralized freeze-dried bone allograft for space maintenance. J Periodontol (2004) 1.01
Matrix molecules and growth factors as indicators of periodontal disease activity. Periodontol 2000 (2003) 0.99
Integrated microfluidic platform for oral diagnostics. Ann N Y Acad Sci (2007) 0.99
Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo. PLoS One (2008) 0.98
Cementoblast delivery for periodontal tissue engineering. J Periodontol (2004) 0.98
Local delivery of osteoprotegerin inhibits mechanically mediated bone modeling in orthodontic tooth movement. Bone (2007) 0.98
Systemic MMP inhibition for periodontal wound repair: results of a multi-centre randomized-controlled clinical trial. J Clin Periodontol (2009) 0.97
Platelet-derived growth factor promotes periodontal regeneration in localized osseous defects: 36-month extension results from a randomized, controlled, double-masked clinical trial. J Periodontol (2012) 0.96
Modified-release subantimicrobial dose doxycycline enhances scaling and root planing in subjects with periodontal disease. J Periodontol (2008) 0.95
Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum. J Periodontol (2004) 0.94
FAM20C functions intracellularly within both ameloblasts and odontoblasts in vivo. J Bone Miner Res (2013) 0.94
Advanced reconstructive technologies for periodontal tissue repair. Periodontol 2000 (2012) 0.94
Bacterial and salivary biomarkers predict the gingival inflammatory profile. J Periodontol (2011) 0.94
Proteomic analysis of enamel matrix using a two-dimensional protein fractionation system. Eur J Oral Sci (2006) 0.94
Pro-inflammatory biomarkers during experimental gingivitis in patients with type 1 diabetes mellitus: a proof-of-concept study. J Clin Periodontol (2009) 0.94
Adenoviral gene transfer of PDGF downregulates gas gene product PDGFalphaR and prolongs ERK and Akt/PKB activation. Am J Physiol Cell Physiol (2002) 0.93
Living cellular construct for increasing the width of keratinized gingiva: results from a randomized, within-patient, controlled trial. J Periodontol (2011) 0.93
Evaluation of functional dynamics during osseointegration and regeneration associated with oral implants. Clin Oral Implants Res (2010) 0.92
Relationships between protein and mineral during enamel development in normal and genetically altered mice. Eur J Oral Sci (2011) 0.92
Sclerostin antibody stimulates bone regeneration after experimental periodontitis. J Bone Miner Res (2013) 0.92
Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical use. Hum Gene Ther (2009) 0.92
Kallikrein-related peptidase 4, matrix metalloproteinase 20, and the maturation of murine and porcine enamel. Eur J Oral Sci (2011) 0.92
Comparative histologic analysis of coronally advanced flap with and without collagen membrane for root coverage. J Periodontol (2002) 0.92
Factors associated with the appearance of gingival papillae. J Clin Periodontol (2010) 0.91
The effect of platelet-rich plasma on the coronally advanced flap root coverage procedure: a pilot human trial. J Periodontol (2005) 0.91
Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration. Tissue Eng Part A (2010) 0.90
Enamel malformations associated with a defined dentin sialophosphoprotein mutation in two families. Eur J Oral Sci (2011) 0.90
Effects of Fam83h overexpression on enamel and dentine formation. Arch Oral Biol (2013) 0.90